Re: News today. Not the whole story.Not the total news we require to Hold or Buy.
1- ipa has completed their own pre-clincal "studies" NOT.. Phases or Trials. Ready to move to
2- clinical preparedness
They will now initiate what will "hopefully" be the final IND [investigational new drug] application
necessary to begin "enabling studies." Not Phase 1,2,3.
H.C.Wainwright & Co.did the PP raise for IPA. The exact same day they did IPA's PP, they did a $70 million PP for Iterum Therapeutics [Dublin, Ireland.]
ITRM Nasdaq. Iterum has a NEW drug pending to treat the many conditions which
are resistant to Antibiotics. A major breakthrough and the first/only drug to do so.
Iterum has completed all 3 of the necessary Phases and applied in early January for FDA approval.
They were given the date July 24th for final review. My point is: how many months or years away is IPA from reaching what Iterum has?
ITRM-Nasdaq trades at $1.13 US and is expected to immediately test previous highs of $6
on [expected] FDA approval before being bought out at multiples.